O’Melveny advised Quick Quack Car Wash and its longtime equity partner Seidler Equity Partners on a significant minority investment by leading global investment firm KKR. KKR...
KKR’s Investment in Quick Quack Car Wash
TaylorMade Golf’s Extended Partnership with Tiger Woods to Launch Sun Day Re
O’Melveny advised TaylorMade Golf on the deal. TaylorMade Golf, a leading manufacturer of high-performance golf equipment, golf balls, and accessories, announced its extended partnership with 15-time...
Beijing Fourth Paradigm Technology’s $150 Million Initial Public Offering
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
Adlai Nortye’s US$100 Million Initial Public Offering
O’Melveny represented Adlai Nortye Ltd. in the transaction. Adlai Nortye Ltd. (NASDAQ: ANL) announced its IPO on the Nasdaq. Adlai Nortye expects to receive aggregate gross...
Ribbon Communications’ US$55 Million Series A Preferred Stock Private Placement Financing
O’Melveny advised B. Riley Securities as Sole Placement Agent on the deal. B. Riley Securities, Inc., a leading middle market investment bank, acted as sole placement...
Bed Bath & Beyond’s Underwritten Public Offering
O’Melveny represented B. Riley Securities, Inc. as sole bookrunner on the deal. Bed Bath & Beyond Inc. (Nasdaq: BBBY) announced the closing of an underwritten public...
Beauty Farm’s Hong Kong IPO and Listing
O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
Cryofocus Medtech’s HK$210 Million IPO
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Belite Bio’s $36 Million IPO
Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...